Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).
Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre
600 participants
Jul 1, 1999
Interventional
Conditions
Summary
Current methods of monitoring the well-being of the unborn baby during labour often result in concern about the unborn baby's health. This leads to delivery by caesarean section, forceps, or vacuum. These babies are usually found to be healthy once born, meaning that the operation was unnecessary. In this study, when an unborn baby appears to be distressed, half of the study participants will be allocated to continue with the current monitoring of the baby's heartbeat. The other half will have a new form of monitoring, fetal oxygen saturation monitoring, added. We will then determine whether the new form of monitoring makes a difference int he number of times women need to have a caesarian section, forceps or vacuum delivery.
Eligibility
Inclusion Criteria1
- Women in labour at > or = 36 weeks gestation with a non-reasuring CTG pattern.
Exclusion Criteria1
- Multiple gestation; non-vertex presentation; placenta praevia; abrnp? placenta; APH; fetal anomaly; known significant viral infection (eg HIV); contraindication to invasive fetal monitoring
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Duration of Study: July 1999 to September 2004. Experimental group receive conventional CTG monitoring plus fetal oxygen saturation monitoring using an internal fetal sensor. Nellcor N-400/FS14 Monitor Purpose: to determine whether the addition of fetal oximetry (oxygen values) to normal monitoring could help reduce the number of times caesarean sections, vacuum and forceps births were performed for concern about the well-being of the baby during labour.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000307505